Tobacco products present a deadly combination of nicotine addiction and carcinogen
exposure resulting in millions of cancer deaths per year worldwide. A plethora of smokeless …

Tobacco harm reduction remains a controversial topic in tobacco control. Tobacco harm
reduction involves providing tobacco users who are unwilling or unable to quit using …

Background: Contemporary data on the prevalence of e-cigarette use in the United States
are limited. Objective: To report the prevalence and distribution of current e-cigarette use …

Background The Aotearoa/New Zealand Government is aiming to end the tobacco epidemic
and markedly reduce Māori: non-Māori health inequalities by legislating:(1) denicotinisation …

Background: Tobacco control efforts implemented in the United States since the 1960s have
led to considerable reductions in smoking and smoking-related diseases, including lung …

Background Adults with HIV have an increased burden of non-AIDS-defining cancers,
myocardial infarction, end-stage liver disease, and end-stage renal disease. The objective of …

This technical report provides the evidence base for the accompanying tobacco clinical
report and policy statement. It builds on, strengthens, and expands AAP recommendations …

Importance The optimal temporal approach for reducing nicotine to minimally or
nonaddictive levels in all cigarettes sold in the United States has not been determined …

Objective Tobacco endgame policies aim to rapidly and permanently reduce smoking to
minimal levels. We reviewed evidence syntheses for:(1) endgame policies,(2) evidence …

Tobacco use is the leading preventable cause of death worldwide and is a major risk factor
for cardiovascular disease (CVD). Both prevention of smoking initiation among youth and …